000			02279nam a22004695i 4500
001			vtls000542407
003			RU-ToGU
005			20210922082402.0
007			cr nn 008mamaa
008			160915s2014 gw | s |||| 0|eng d
020			_a9783319030593 _9978-3-319-03059-3
024	7		_a10.1007/978-3-319-03059-3 _2doi
035			_ato000542407
040			_aSpringer _cSpringer _dRU-ToGU
050		4	_aR1
072		7	_aMB _2bicssc
072		7	_aMED000000 _2bisacsh
082	0	4	_a610 _223
100	1		_aCappuzzo, Federico. _eauthor. _9448516
245	1	0	_aGuide to Targeted Therapies: EGFR mutations in NSCLC _helectronic resource _cby Federico Cappuzzo.
260			_aCham : _bSpringer International Publishing : _bImprint: Adis, _c2014.
300			_aXI, 67 p. 16 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
505	0		_aIntroduction -- The Human Epidermal growth factor Receptor (HER) family: structure and function -- Methods for EGFR mutation testing -- Predictive and prognostic implications of EGFR mutations -- EGFR-targeted therapies in non‑small cell lung cancer -- Conclusions.
520			_aGuide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.
650		0	_amedicine. _9566220
650		0	_aPneumology. _9304224
650		0	_aOncology. _9303086
650	1	4	_aMedicine & Public Health. _9566221
650	2	4	_aMedicine/Public Health, general. _9265983
650	2	4	_aOncology. _9303086
650	2	4	_aPharmacotherapy. _9428996
650	2	4	_aPneumology/Respiratory System. _9304226
710	2		_aSpringerLink (Online service) _9143950
773	0		_tSpringer eBooks
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-319-03059-3
912			_aZDB-2-SME
999			_c400199